AGIO - Agios Pharm - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AGIO is currently covered by 7 analysts with an average price target of $45.26. This is a potential upside of $17.94 (65.67%) from yesterday's end of day stock price of $27.32.

Agios Pharm's activity chart (see below) currently has 128 price targets and 113 ratings on display. The stock rating distribution of AGIO is 69.57% BUY and 30.43% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.02% with an average time for these price targets to be met of 132.15 days.

Highest price target for AGIO is $71, Lowest price target is $46, average price target is $55.29.

Most recent stock forecast was given by GREG HARRISON from SCOTIABANK on 02-May-2025. First documented stock forecast 19-Aug-2013.

Currently out of the existing stock ratings of AGIO, 16 are a BUY (69.57%), 7 are a HOLD (30.43%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$71

$43.68 (159.88%)

$75

10 days ago
(02-May-2025)

6/8 (75%)

$40.9 (135.88%)

477

Buy

$57

$29.68 (108.64%)

$55

5 months 2 days ago
(09-Dec-2024)

5/6 (83.33%)

$10.98 (23.86%)

84

Buy

$51

$23.68 (86.68%)

7 months 2 days ago
(10-Oct-2024)

1/1 (100%)

$9.18 (21.95%)

27

Hold

$56

$28.68 (104.98%)

$61

7 months 15 days ago
(27-Sep-2024)

10/13 (76.92%)

$10.39 (22.78%)

223

Hold

$46

$18.68 (68.37%)

$30

10 months 29 days ago
(13-Jun-2024)

4/4 (100%)

$-0.77 (-1.65%)

169

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AGIO (Agios Pharm) average time for price targets to be met?

On average it took 132.15 days on average for the stock forecasts to be realized with a an average price target met ratio 65.02

Which analyst has the current highest performing score on AGIO (Agios Pharm) with a proven track record?

JOHN NEWMAN

Which analyst has the most public recommendations on AGIO (Agios Pharm)?

John Newman works at CANACCORD and has 5 price targets and 4 ratings on AGIO

Which analyst is the currently most bullish on AGIO (Agios Pharm)?

Yatin Suneja with highest potential upside - $87.68

Which analyst is the currently most reserved on AGIO (Agios Pharm)?

Chad Messer with lowest potential downside - -$0

Agios Pharm in the News

Agios Pharmaceuticals' (NASDAQ:AGIO) Attractive Earnings Are Not All Good News For Shareholders

We didn’t see Agios Pharmaceuticals, Inc.’s (NASDAQ:AGIO) stock surge when it reported robust earnings recently. We decided to have a deeper look, and we believe that investors might be worried about several concerning factors that we found. Trump has pledged to “unleash” American oil and gas and these 15 US stocks have developments that are...

Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025

CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the 2025 RBC Capital Markets Global Healthcare Conference on Wednesday, May 21, 2025, at 8:00 am ET. The...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?